Sun Pharma to acquire Nasdaq-listed DUSA Pharma for $230M
Mumbai-based Sun Pharma Industries Ltd, India’s largest pharmaceutical company by market capitalisation, has struck another large overseas acquisition to buy NASDAQ-listed dermatology company DUSA Pharmaceuticals, Inc., for $230 million in cash.
DUSA is focused on developing and marketing...
A Premium membership gives you:
- Access to all premium articles including exclusives, analyses & commentary.
- Access to archives of over six years.
- Exclusive interviews with top fund managers, CEOs and bankers.